PCM
EVH icon

Palisade Capital Management’s Evolent Health EVH Stock Holding History

Palisade Capital Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-29,382
Closed -$209K – 398
2020
Q2 		$209K Sell
29,382
-4,015
-12% -$26.9K 0.01% 374
2020
Q1 		$181K Sell
33,397
-14,127
-30% -$126K 0.01% 406
2019
Q4 		$430K Buy
+47,524
New +$386K 0.01% 362

Other funds holding EVH

EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Palisade Capital Management's EVH Position: Q3 2020 in Review

Palisade Capital Management sold out of Evolent Health (EVH) in Q3 2020, closing a stake of 29,382 shares — an estimated $209K sold.

Palisade Capital Management first reported a position in EVH in Q4 2019 and held it in 3 quarters. The position peaked at $430K in Q4 2019. 155 funds tracked by Wall St. Rank hold EVH as of Q3 2020.

  • Palisade Capital Management reported no remaining Evolent Health position as of Q3 2020 after selling out during the quarter.
  • Palisade Capital Management sold 29,382 Evolent Health shares in Q3 2020, an estimated $209K.
  • Palisade Capital Management first reported a position in Evolent Health in Q4 2019 and held it in 3 quarters.
  • Palisade Capital Management's Evolent Health position peaked at $430K in Q4 2019.
  • 155 funds tracked by Wall St. Rank held Evolent Health as of Q3 2020.

Based on Palisade Capital Management's 13F filing for Q3 2020, filed 12 Nov 2020.